{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:38Z","timestamp":1786984298808,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":680,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000869","name":"Susan G. Komen for the Cure","doi-asserted-by":"publisher","award":["HFHS F11047"],"award-info":[{"award-number":["HFHS F11047"]}],"id":[{"id":"10.13039\/100000869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajp.amjpathol.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ajpath.2017.06.020","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T10:52:46Z","timestamp":1512643966000},"page":"271-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Triple-Negative Breast Cancer, Stem Cells, and African Ancestry"],"prefix":"10.1016","volume":"188","author":[{"given":"Evelyn","family":"Jiagge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjay","family":"Chitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2017.06.020_bib1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","article-title":"Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature","volume":"69","author":"Charafe-Jauffret","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1101\/gad.1061803","article-title":"In\u00a0vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells","volume":"17","author":"Dontu","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2017.06.020_bib3","doi-asserted-by":"crossref","first-page":"djv048","DOI":"10.1093\/jnci\/djv048","article-title":"Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race\/ethnicity, poverty, and state","volume":"107","author":"Kohler","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2017.06.020_bib4","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1245\/s10434-014-4279-0","article-title":"The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer","volume":"22","author":"Newman","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib5","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1245\/s10434-016-5420-z","article-title":"Comparative analysis of breast cancer phenotypes in African American, White American, and West versus East African patients: correlation between African ancestry and triple-negative breast cancer","volume":"23","author":"Jiagge","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib6","doi-asserted-by":"crossref","first-page":"e625","DOI":"10.1016\/S1470-2045(14)70364-X","article-title":"Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry","volume":"15","author":"Brewster","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib7","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.7150\/ijbs.16874","article-title":"Evaluation of breast cancer stem cells and intratumor stemness heterogeneity in triple-negative breast cancer as prognostic factors","volume":"12","author":"Yang","year":"2016","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ajpath.2017.06.020_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/modpathol.2012.37","article-title":"Stem cell-related markers in primary breast cancers and associated metastatic lesions","volume":"25","author":"Guler","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1471-2407-11-418","article-title":"CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers","volume":"11","author":"Olsson","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajpath.2017.06.020_bib10","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/bcr2108","article-title":"The CD44+\/CD24\u2212 phenotype is enriched in basal-like breast tumors","volume":"10","author":"Honeth","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/cncr.27737","article-title":"Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women","volume":"119","author":"Schwartz","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2017.06.020_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.bjc.6605488","article-title":"Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer","volume":"102","author":"Nalwoga","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2017.06.020_bib13","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1038\/srep13526","article-title":"Ethnicity-dependent and -independent heterogeneity in healthy normal breast hierarchy impacts tumor characterization","volume":"5","author":"Nakshatri","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2017.06.020_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-012-2055-z","article-title":"Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression","volume":"135","author":"Pang","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2017.06.020_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jamasurg.2017.0005","article-title":"Health disparities and triple-negative breast cancer in African American women: a review","volume":"152","author":"Newman","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ajpath.2017.06.020_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3322\/caac.21320","article-title":"Breast cancer statistics, 2015: convergence of incidence rates between black and white women","volume":"66","author":"DeSantis","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2017.06.020_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0027-9684(15)31294-3","article-title":"Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology","volume":"100","author":"Baquet","year":"2008","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.ajpath.2017.06.020_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10552-004-1263-1","article-title":"Disparities across the breast cancer continuum","volume":"16","author":"Bigby","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ajpath.2017.06.020_bib19","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s10552-013-0246-5","article-title":"Disparities in survival after female breast cancer diagnosis: a population-based study","volume":"24","author":"Tannenbaum","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ajpath.2017.06.020_bib20","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.whi.2011.11.007","article-title":"Identifying risk factors for disparities in breast cancer mortality among African-American and Hispanic women","volume":"22","author":"Tian","year":"2012","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.ajpath.2017.06.020_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jss.2008.05.020","article-title":"Racial disparities in breast cancer survival: an analysis by age and stage","volume":"153","author":"Deshpande","year":"2009","journal-title":"J Surg Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1200\/JCO.2015.65.1877","article-title":"Parsing the etiology of breast cancer disparities","volume":"34","author":"Newman","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib23","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1002\/cncr.10575","article-title":"African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast","volume":"94","author":"Newman","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2017.06.020_bib24","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1200\/JCO.2005.03.3472","article-title":"Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status","volume":"24","author":"Newman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/jnci\/djp175","article-title":"Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group","volume":"101","author":"Albain","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2017.06.020_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/jnci\/dji064","article-title":"Ethnicity and breast cancer: factors influencing differences in incidence and outcome","volume":"97","author":"Chlebowski","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2017.06.020_bib27","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/cncr.25862","article-title":"Higher population-based incidence rates of triple-negative breast cancer among young African-American women: implications for breast cancer screening recommendations","volume":"117","author":"Amirikia","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2017.06.020_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-015-3528-7","article-title":"Breast cancer survival in African-American women by hormone receptor subtypes","volume":"153","author":"Akinyemiju","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2017.06.020_bib29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s40064-015-1282-2","article-title":"Socioeconomic status and incidence of breast cancer by hormone receptor subtype","volume":"4","author":"Akinyemiju","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.ajpath.2017.06.020_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/tbj.12369","article-title":"Disparities in breast cancer and African ancestry: a global perspective","volume":"21","author":"Newman","year":"2015","journal-title":"Breast J"},{"key":"10.1016\/j.ajpath.2017.06.020_bib31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1245\/s10434-014-4345-7","article-title":"Global surgical oncology disease burden: addressing disparities via global surgery initiatives: the University of Michigan International Breast Cancer Registry","volume":"22","author":"Jiagge","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib32","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1200\/JCO.2008.19.6873","article-title":"Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer","volume":"27","author":"Huo","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000341541","article-title":"High incidence of triple-negative tumors in sub-Saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital","volume":"83","author":"Ly","year":"2012","journal-title":"Oncology"},{"key":"10.1016\/j.ajpath.2017.06.020_bib34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/tbj.12527","article-title":"Triple-negative breast cancer in Ghanaian women: the Korle Bu Teaching Hospital experience","volume":"21","author":"Der","year":"2015","journal-title":"Breast J"},{"key":"10.1016\/j.ajpath.2017.06.020_bib35","first-page":"8","article-title":"Breast cancer in Kumasi, Ghana","volume":"46","author":"Ohene-Yeboah","year":"2012","journal-title":"Ghana Med J"},{"key":"10.1016\/j.ajpath.2017.06.020_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4103\/1119-3077.156905","article-title":"Pattern of hormone receptors and human epidermal growth factor receptor 2 status in sub-Saharan breast cancer cases: private practice experience","volume":"18","author":"Nwafor","year":"2015","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.ajpath.2017.06.020_bib37","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1245\/s10434-015-4455-x","article-title":"Characterizing breast cancer in a population with increased prevalence of triple-negative breast cancer: androgen receptor and ALDH1 expression in Ghanaian women","volume":"22","author":"Proctor","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1472-6874-12-35","article-title":"Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology","volume":"12","author":"Rais","year":"2012","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ajpath.2017.06.020_bib39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/1756-0500-5-436","article-title":"Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study","volume":"5","author":"Bennis","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ajpath.2017.06.020_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1472-6874-11-44","article-title":"Molecular subtype analysis determines the association of advanced breast cancer in Egypt with favorable biology","volume":"11","author":"Salhia","year":"2011","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ajpath.2017.06.020_bib41","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/apm.12241","article-title":"Immunohistochemical expression of GPR30 in breast carcinoma of Egyptian patients: an association with immunohistochemical subtypes","volume":"122","author":"Aiad","year":"2014","journal-title":"APMIS"},{"key":"10.1016\/j.ajpath.2017.06.020_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gde.2014.09.003","article-title":"The peopling of the African continent and the diaspora into the new world","volume":"29","author":"Campbell","year":"2014","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.ajpath.2017.06.020_bib43","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2017.06.020_bib44","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","article-title":"Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer","volume":"21","author":"Burstein","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib45","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1158\/1078-0432.CCR-13-0799","article-title":"Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes","volume":"19","author":"Masuda","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib46","doi-asserted-by":"crossref","first-page":"e0157368","DOI":"10.1371\/journal.pone.0157368","article-title":"Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection","volume":"11","author":"Lehmann","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2017.06.020_bib47","doi-asserted-by":"crossref","first-page":"e71915","DOI":"10.1371\/journal.pone.0071915","article-title":"Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy","volume":"8","author":"Lindner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2017.06.020_bib48","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2015.62.2126","article-title":"Comparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial differences with tumor recurrence","volume":"33","author":"Keenan","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib49","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10549-016-4062-y","article-title":"Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians","volume":"161","author":"Ademuyiwa","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2017.06.020_bib50","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/jamaoncol.2017.0595","article-title":"Comparison of breast cancer molecular features and survival by African and European ancestry in the cancer genome atlas","volume":"3","author":"Huo","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib51","doi-asserted-by":"crossref","first-page":"e4531","DOI":"10.1371\/journal.pone.0004531","article-title":"Differences in the tumor microenvironment between African-American and European-American breast cancer patients","volume":"4","author":"Martin","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2017.06.020_bib52","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/cncr.26405","article-title":"Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women","volume":"118","author":"Field","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2017.06.020_bib53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1756-0500-5-248","article-title":"Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer","volume":"5","author":"Grunda","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ajpath.2017.06.020_bib54","doi-asserted-by":"crossref","first-page":"e82460","DOI":"10.1371\/journal.pone.0082460","article-title":"Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer","volume":"8","author":"Stewart","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2017.06.020_bib55","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10549-014-2899-5","article-title":"Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression","volume":"144","author":"Kroenke","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2017.06.020_bib56","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1158\/1055-9965.EPI-13-1023","article-title":"Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics","volume":"23","author":"Sweeney","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajpath.2017.06.020_bib57","first-page":"23","article-title":"Does race affect outcomes in triple negative breast cancer?","volume":"4","author":"Sachdev","year":"2010","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ajpath.2017.06.020_bib58","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1200\/JCO.2008.17.9952","article-title":"Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes","volume":"27","author":"Dawood","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib59","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1158\/1078-0432.CCR-10-1533","article-title":"Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study","volume":"16","author":"O'Brien","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib60","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-008-9926-3","article-title":"Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA","volume":"113","author":"Lund","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2017.06.020_bib61","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1242\/dev.125.10.1921","article-title":"An entire functional mammary gland may comprise the progeny from a single cell","volume":"125","author":"Kordon","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.ajpath.2017.06.020_bib62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/213193a0","article-title":"Transplantability and life span of mammary gland during serial transplantation in mice","volume":"213","author":"Hoshino","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2017.06.020_bib63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/his.12868","article-title":"Breast cancer stem cells: are we ready to go from bench to bedside?","volume":"68","author":"Lin","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.ajpath.2017.06.020_bib64","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2017.06.020_bib65","doi-asserted-by":"crossref","first-page":"10675","DOI":"10.18632\/oncotarget.12893","article-title":"Mammary gland stem cells and their application in breast cancer","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2017.06.020_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13058-016-0688-2","article-title":"Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells","volume":"18","author":"Weigand","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/bcr1540","article-title":"Identification of murine mammary stem cells: implications for studies of mammary development and carcinogenesis","volume":"8","author":"Wicha","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2519-3_1","article-title":"Breast cancer stem cells: current advances and clinical implications","volume":"1293","author":"Luo","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2017.06.020_bib70","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1200\/JCO.2009.27.5388","article-title":"Targeting breast cancer stem cells","volume":"28","author":"Liu","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib71","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ajpath.2017.06.020_bib72","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/1471-2407-14-444","article-title":"ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajpath.2017.06.020_bib73","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2016.01.027","article-title":"Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in\u00a0vitro and inhibits tumor growth in a subcutaneous mouse tumor model","volume":"372","author":"Amoury","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2017.06.020_bib74","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1381612821666141211120604","article-title":"Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance","volume":"21","author":"Luo","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ajpath.2017.06.020_bib75","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jcp.2011.090456","article-title":"Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype","volume":"64","author":"Ricardo","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ajpath.2017.06.020_bib76","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/bcr1610","article-title":"CD44+\/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis","volume":"8","author":"Sheridan","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib77","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/onc.2008.207","article-title":"HER2 regulates the mammary stem\/progenitor cell population driving tumorigenesis and invasion","volume":"27","author":"Korkaya","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2017.06.020_bib78","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/1078-0432.CCR-09-1532","article-title":"Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer","volume":"16","author":"Park","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib79","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1158\/0008-5472.CAN-13-0260","article-title":"HER2 and breast cancer stem cells: more than meets the eye","volume":"73","author":"Korkaya","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib80","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-12-3349","article-title":"HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab","volume":"73","author":"Ithimakin","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2017.06.020_bib81","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cam4.690","article-title":"Role of cancer stem cells in racial disparity in colorectal cancer","volume":"5","author":"Farhana","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.ajpath.2017.06.020_bib82","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4252\/wjsc.v8.i9.279","article-title":"Racial disparity in colorectal cancer: gut microbiome and cancer stem cells","volume":"8","author":"Goyal","year":"2016","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.ajpath.2017.06.020_bib83","doi-asserted-by":"crossref","first-page":"15234","DOI":"10.1038\/srep15234","article-title":"Derivation of ethnically diverse human induced pluripotent stem cell lines","volume":"5","author":"Chang","year":"2015","journal-title":"Sci Rep"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017303899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944017303899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T21:23:26Z","timestamp":1660080206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944017303899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0002944017303899"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2017.06.020","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple-Negative Breast Cancer, Stem Cells, and African Ancestry","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2017.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}